Glazer Capital »

Biomarin Pharma Inc convertible/ shares owned by Glazer Capital

Quarter-by-quarter ownership of Biomarin Pharma Inc convertible/ shares owned by Glazer Capital from 13F filings

Historical chart of Glazer Capital investment in Biomarin Pharma Inc convertible/

Tip: Access up to 7 years of quarterly data

All positions including Biomarin Pharma Inc convertible/ held by Glazer Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biomarin Pharma Inc convertible/ by Glazer Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $30M 30M 0.99

More positions owned by Glazer Capital

Squarespace Class A (SQSP)
Encore Wire Corporation (WIRE)
National Westn Life Group In Cl A (NWLI)
Everbridge, Inc. Cmn (EVBG)
Hollysys Automation Tchngy L SHS (HOLI)
Assetmark Financial Hldg (AMK)
Endeavor Group Hldgs Cl A Com (EDR)
Powerschool Holdings Com Cl A
Perficient (PRFT)
Us Silica Hldgs (SLCA)
Blackline Note 0.125% 8/0 (Principal)
Brookfield Corp Cl A Ltd Vt Sh (BN)
Biomarin Pharmaceutical Note 0.599% 8/0 (Principal)
Overseas Shipholding Group I Cl A New (OSG)
Equitrans Midstream Corp (ETRN)

View all positions for Glazer Capital

Top funds holding Biomarin Pharma Inc convertible/

Osterweis Capital Management
OZ Management
Millennium Management
Lazard Asset Management
Glazer Capital
Citigroup
Aviva
Tenor Capital Management
Piper Jaffray & Co.
Partner Fund Management
Jpmorgan Chase & Co
State Street Corporation
Branch Banking & Trust Company
Kohlberg Kravis Roberts & Co
Palisade Capital Management

View all funds holding Biomarin Pharma Inc convertible/